[go: up one dir, main page]

GB0128612D0 - Aerosol formulations - Google Patents

Aerosol formulations

Info

Publication number
GB0128612D0
GB0128612D0 GB0128612A GB0128612A GB0128612D0 GB 0128612 D0 GB0128612 D0 GB 0128612D0 GB 0128612 A GB0128612 A GB 0128612A GB 0128612 A GB0128612 A GB 0128612A GB 0128612 D0 GB0128612 D0 GB 0128612D0
Authority
GB
United Kingdom
Prior art keywords
aerosol formulations
aerosol
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0128612A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0128612A priority Critical patent/GB0128612D0/en
Priority to KR1020037008530A priority patent/KR100881258B1/en
Priority to NZ526564A priority patent/NZ526564A/en
Priority to CNA018228275A priority patent/CN1638830A/en
Priority to HU0400600A priority patent/HU229899B1/en
Priority to JP2002552624A priority patent/JP2004520107A/en
Priority to IL15630801A priority patent/IL156308A0/en
Priority to US10/451,444 priority patent/US20040050960A1/en
Priority to PCT/GB2001/005749 priority patent/WO2002051483A1/en
Priority to MXPA03005697A priority patent/MXPA03005697A/en
Priority to BR0116396-5A priority patent/BR0116396A/en
Priority to CZ2003-1742A priority patent/CZ305498B6/en
Priority to PL364773A priority patent/PL204659B1/en
Priority to EP01272108.0A priority patent/EP1343550B1/en
Priority to AU2002222304A priority patent/AU2002222304B2/en
Priority to ES01272108.0T priority patent/ES2656210T3/en
Priority to CA002431910A priority patent/CA2431910A1/en
Publication of GB0128612D0 publication Critical patent/GB0128612D0/en
Priority to IL156308A priority patent/IL156308A/en
Priority to NO20032836A priority patent/NO336840B1/en
Priority to JP2009022343A priority patent/JP2009142663A/en
Ceased legal-status Critical Current

Links

GB0128612A 2000-12-22 2001-11-29 Aerosol formulations Ceased GB0128612D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0128612A GB0128612D0 (en) 2001-11-29 2001-11-29 Aerosol formulations
MXPA03005697A MXPA03005697A (en) 2000-12-22 2001-12-21 DOSE INHALER MEASURE FOR SALMETEROL XINAFOATE.
PL364773A PL204659B1 (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
CNA018228275A CN1638830A (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
HU0400600A HU229899B1 (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
JP2002552624A JP2004520107A (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
IL15630801A IL156308A0 (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
US10/451,444 US20040050960A1 (en) 2000-12-22 2001-12-21 Metered dose inhaler for salemeterol xinafoate
PCT/GB2001/005749 WO2002051483A1 (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
KR1020037008530A KR100881258B1 (en) 2000-12-22 2001-12-21 Quantitative Inhalers for Salmeterol Ginapoate
BR0116396-5A BR0116396A (en) 2000-12-22 2001-12-21 Container, metered dose inhaler, asthma or copd treatment method, and packaging
CZ2003-1742A CZ305498B6 (en) 2000-12-22 2001-12-21 Container
NZ526564A NZ526564A (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
EP01272108.0A EP1343550B1 (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
AU2002222304A AU2002222304B2 (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
ES01272108.0T ES2656210T3 (en) 2000-12-22 2001-12-21 Dosing inhaler for salmeterol xinafoate
CA002431910A CA2431910A1 (en) 2000-12-22 2001-12-21 Metered dose inhaler for salmeterol xinafoate
IL156308A IL156308A (en) 2000-12-22 2003-06-04 Metered dose inhaler for salmeterol xinafoate
NO20032836A NO336840B1 (en) 2000-12-22 2003-06-20 Container for metered dose inhaler
JP2009022343A JP2009142663A (en) 2000-12-22 2009-02-03 Metered inhaler for salmeterol xinafoate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0128612A GB0128612D0 (en) 2001-11-29 2001-11-29 Aerosol formulations

Publications (1)

Publication Number Publication Date
GB0128612D0 true GB0128612D0 (en) 2002-01-23

Family

ID=9926687

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0128612A Ceased GB0128612D0 (en) 2000-12-22 2001-11-29 Aerosol formulations

Country Status (1)

Country Link
GB (1) GB0128612D0 (en)

Similar Documents

Publication Publication Date Title
GB0319041D0 (en) Pharmaceutical Formulations
AU148104S (en) Plug-in aerosol dispenser
GB0009583D0 (en) Respiratory formulations
AU2002234476A1 (en) Medical aerosol formulations
IL161596A0 (en) Pesticidal formulations
GB0121715D0 (en) Pharmaceutical formulations
GB2380129B (en) Pharmaceutical formulations
GB0106601D0 (en) Antiperspirant formulations
GB0120701D0 (en) Pharmaceutical formulations
GB0103638D0 (en) Pharmaceutical formulations
GB0015490D0 (en) Novel formulations
GB0116945D0 (en) Antiperspirant formulations
GB0116946D0 (en) Antiperspirant formulations
GB0105560D0 (en) Pharmaceutical formulations
GB0121436D0 (en) Biomodulated multiparticulate formulations
AU149297S (en) Aerosol dispenser
GB0125492D0 (en) Formulation
GB0110681D0 (en) Antiperspirant formulations
GB0124455D0 (en) Pharmaceutical formulations
GB0115893D0 (en) Formulations
GB0128612D0 (en) Aerosol formulations
GB2396812B (en) Formulation
GB2375048B (en) Formulation
GB0101790D0 (en) Aerosol monitor
GB0116619D0 (en) Formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)